Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2026January › 30

AstraZeneca

5 months ago

Under the deal, the FTSE 100 group will have the exclusive global rights, outside China, to CSPC's once-a-month jab that is about to start early-stage clinical trials.
Drugmaker expands push into fast-growing market

page 1 of 1